You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


AbbVie and Eli Lilly snub drug pricing agreement

Global pharma giants, AbbVie and Eli Lilly and Company (Lilly), have shocked the UK Government by leaving the voluntary medicines pricing agreement. The move is a response to increasingly punishing revenue clawbacks.